3 Charts You Have to See Before Buying Moderna
Shares of Moderna (NASDAQ: MRNA) are down more than 30% in 2022 (the S&P 500 has only declined by 4%), and you may be wondering if now is the time to buy it on the dip. Many investors are bullish on the company's future, especially with Moderna working on new mRNA vaccines in its pipeline.
But before you decide to invest in the stock, you should take a careful look at the following charts below. Although the company has done well this past year and looks to have a strong 2022, there are challenges ahead that could make Moderna a risky stock to hang on to from here.
Image source: Getty Images.
Source Fool.com
